The Patent Finder

Innate Tumor Immunity, Inc.

22 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as IFM Therapeutics, Inc. (to 2018)

0
Ending by 2030
Jan 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due May 28, 2027
  • 2 fees due Jul 14, 2027
  • 1 fee due Aug 11, 2027
    The maintenance fee for NLRP3 modulators (US 10,556,903) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 1 fee due Sep 30, 2027
    The maintenance fee for Cyclic dinucleotides for treating conditions associated with sting activity such as cancer (US 10,604,542) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,604,542Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,723,756Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,961,270Compounds and compositions for treating conditions associated with sting activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,505,571Compounds and compositions for treating conditions associated with sting activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,533,007NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,556,903NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,072,612NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,533,005NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,351,580NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,827,632NLRP3 modulators
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited